Following reports that higher levels of follistatin are associated with an increased risk of type 2 diabetes and PCOS, a paper presented in Frontiers in Endocrinology investigated the effects of treatment of non-obese adolescent girls with PCOS on follistatin concentrations. This evidence concerns the gene FST and polycystic ovary syndrome.